243 related articles for article (PubMed ID: 16171107)
1. [The 4th large meta-analysis of all trials of the treatment of operable breast cancer: increased survival after a longer follow-up].
van Nes JG; Nortier WR; van de Velde CJ
Ned Tijdschr Geneeskd; 2005 Sep; 149(36):1978-80. PubMed ID: 16171107
[TBL] [Abstract][Full Text] [Related]
2. Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective.
Gebski V; Lagleva M; Keech A; Simes J; Langlands AO
J Natl Cancer Inst; 2006 Jan; 98(1):26-38. PubMed ID: 16391369
[TBL] [Abstract][Full Text] [Related]
3. Primary chemotherapy in breast cancer.
Smith IE; al-Moundhri M
Biomed Pharmacother; 1998; 52(3):116-21. PubMed ID: 9755804
[TBL] [Abstract][Full Text] [Related]
4. The use of third-generation aromatase inhibitors and tamoxifen in the adjuvant treatment of postmenopausal patients with hormone-dependent breast cancer: evidence based review.
Poole R; Paridaens R
Curr Opin Oncol; 2007 Nov; 19(6):564-72. PubMed ID: 17906453
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy for operable breast cancer.
Mieog JS; van der Hage JA; van de Velde CJ
Br J Surg; 2007 Oct; 94(10):1189-200. PubMed ID: 17701939
[TBL] [Abstract][Full Text] [Related]
6. [Meta-analyses of the effects of radiotherapy in breast cancer: the ultimate evidence?].
Fourquet A; Kirova Y; Bollet MA; Tournat H; Dendale R; Campana F
Cancer Radiother; 2008 Nov; 12(6-7):554-8. PubMed ID: 18838328
[TBL] [Abstract][Full Text] [Related]
7. Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.
Mauri D; Pavlidis N; Polyzos NP; Ioannidis JP
J Natl Cancer Inst; 2006 Sep; 98(18):1285-91. PubMed ID: 16985247
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer in the elderly.
Crivellari D; Aapro M; Leonard R; von Minckwitz G; Brain E; Goldhirsch A; Veronesi A; Muss H
J Clin Oncol; 2007 May; 25(14):1882-90. PubMed ID: 17488987
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy of breast cancer.
Kaklamani VG; Gradishar WJ
Cancer Invest; 2005; 23(6):548-60. PubMed ID: 16203663
[TBL] [Abstract][Full Text] [Related]
10. Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer.
Berry J
Clin Ther; 2005 Nov; 27(11):1671-84. PubMed ID: 16368441
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant radiotherapy for breast cancer: effects of longer follow-up.
Van de Steene J; Vinh-Hung V; Cutuli B; Storme G
Radiother Oncol; 2004 Jul; 72(1):35-43. PubMed ID: 15236872
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant therapy with aromatase inhibitors for postmenopausal women with early breast cancer: evidence and ongoing controversy.
Wheler J; Johnson M; Seidman A
Semin Oncol; 2006 Dec; 33(6):672-80. PubMed ID: 17145347
[TBL] [Abstract][Full Text] [Related]
13. Is adjuvant therapy for older patients with node (+) early breast cancer cost-effective?
Naeim A; Keeler EB
Breast Cancer Res Treat; 2005 Nov; 94(2):95-103. PubMed ID: 16261407
[TBL] [Abstract][Full Text] [Related]
14. Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group.
Morales L; Canney P; Dyczka J; Rutgers E; Coleman R; Cufer T; Welnicka-Jaskiewicz M; Nortier J; Bogaerts J; Therasse P; Paridaens R; ;
Eur J Cancer; 2007 Jan; 43(2):331-40. PubMed ID: 17134892
[TBL] [Abstract][Full Text] [Related]
15. Herceptin in early breast cancer: a call for judicious use.
Thorat MA
Natl Med J India; 2005; 18(6):315-7. PubMed ID: 16483033
[No Abstract] [Full Text] [Related]
16. Survival after adjuvant oophorectomy and tamoxifen in operable breast cancer in premenopausal women.
Love RR; Van Dinh N; Quy TT; Linh ND; Tung ND; Shen TZ; Hade EM; Young GS; Jarjoura D
J Clin Oncol; 2008 Jan; 26(2):253-7. PubMed ID: 18086800
[TBL] [Abstract][Full Text] [Related]
17. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.
Pentheroudakis G; Fountzilas G; Bafaloukos D; Koutsoukou V; Pectasides D; Skarlos D; Samantas E; Kalofonos HP; Gogas H; Pavlidis N
Breast Cancer Res Treat; 2006 Jun; 97(3):237-44. PubMed ID: 16322882
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy for breast cancer--"one fits all"?
Bergh J
Breast; 2005 Dec; 14(6):564-9. PubMed ID: 16243525
[TBL] [Abstract][Full Text] [Related]
19. Special issues related to breast cancer adjuvant therapy in older women.
Witherby SM; Muss HB
Breast; 2005 Dec; 14(6):600-11. PubMed ID: 16198568
[TBL] [Abstract][Full Text] [Related]
20. [New combination chemotherapy regimens in the primary treatment of operable breast cancer].
Conti F; Sergi D; Foggi P; Abbate MI; Lopez M
Clin Ter; 2007; 158(1):55-75. PubMed ID: 17405660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
